The role of idelalisib in the treatment of relapsed and refractory chronic lymphocytic leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 2, p. 69, doi. 10.1177/2040620715625966
- By:
- Publication type:
- Article
Works matching IS 20406207 AND DT 2016 AND VI 7 AND IP 2
Results: 4
1
2
The evolving role of response-adapted PET imaging in Hodgkin lymphoma.
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 2, p. 108, doi. 10.1177/2040620715625615
- By:
- Publication type:
- Article
3
Hepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 2, p. 94, doi. 10.1177/2040620715623924
- By:
- Publication type:
- Article
4
Obinutuzumab for relapsed or refractory indolent non-Hodgkin's lymphomas.
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 2, p. 85, doi. 10.1177/2040620715622613
- By:
- Publication type:
- Article